Purpose To compare the visualization of hemodynamic imaging findings of hypervascular hepatocellular carcinoma (HCC) on dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) using radial volumetric imaging breath-hold examination with k-space-weighted image contrast reconstruction (r-VIBE-KWIC) versus dynamic computed tomography during hepatic arteriography (dyn-CTHA).
Introduction
Evaluation of the arterial blood flow of the nodules is extremely useful in differentiation between advanced hepatocellular carcinoma (HCC) from early HCC and dysplastic nodules [1, 2] , and it is important to determine the most appropriate therapeutic strategy [3] . The hemodynamic characteristics of HCC have been radiologically analyzed using various diagnostic imaging techniques such as dynamic contrast-enhanced computed tomography (CT) and CT during hepatic arteriography (CTHA). Single-level dynamic CTHA (dyn-CTHA) features high spatial and temporal resolution and is able to demonstrate the hemodynamic characteristics of HCC such as arterial hypervascularity, corona enhancement of the surrounding liver, and the washout phenomenon of arterial staining; it has historically been considered the gold standard method for hemodynamic analysis of HCC [4, 5] . However, CTHA is a critically invasive technique with the drawback of radiation exposure. Dynamic contrastenhanced CT is less invasive than CTHA but also involves radiation exposure.
In contrast, magnetic resonance imaging (MRI) is less invasive and involves no radiation exposure. Dynamic contrast-enhanced MRI (DCE-MRI) is available for dynamic study of the hemodynamics of HCC. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA), a hepatocyte-specific contrast agent, has been used worldwide for DCE-MRI of the liver. However, the volume used is half that of a nonspecific extracellular contrast agent; therefore, the adequate duration of acquisition is narrow, and it is difficult to obtain an optimal arterial phase. New three-dimensional gradient-echo sequences in MRI with high spatial and temporal resolution were recently developed and have been clinically applied. One of these techniques is the radial volumetric imaging breath-hold examination (r-VIBE), which is a modified version of Cartesian (traditional) VIBE (c-VIBE). The r-VIBE sequence offers several advantages over the c-VIBE sequence, including less motion sensitivity, the absence of aliasing artifact, and less degradation of the image quality due to undersampling [6, 7] . Furthermore, r-VIBE with k-space-weighted image contrast reconstruction (r-VIBE-KWIC) allows for powerful view-sharing and provides high-temporal-resolution subframe (time-resolved) images as well as a full-frame image, and optimal arterial images can be obtained in over 90% [8] . Therefore, without an invasive procedure or radiation exposure, DCE-MRI using r-VIBE-KWIC has the potential to provide images with high temporal and spatial resolution that are as useful as dyn-CTHA for both detection and characterization of hypervascular hepatic lesions.
We compared the visualization of hemodynamic imaging findings of hypervascular HCC on DCE-MRI using r-VIBE-KWIC versus dyn-CTHA.
Materials and methods
This study was approved by the institutional review board of our hospital, and written informed consent was obtained from all of the enrolled patients.
Patients
We retrospectively reviewed the DCE-MRI, dyn-CTHA, and pathology databases in our institution. From March 2012 to November 2012, 36 consecutive patients whose liver nodules had been wholly resected and histologically diagnosed as HCC were enrolled in this study. Of the 36 patients, 3 did not undergo DCE-MRI using r-VIBE-KWIC, 13 did not undergo dyn-CTHA, and 4 did not undergo either examination. One patient had a huge tumor and portal vein thrombus, and one patient had a hypovascular HCC on dynamic contrast-enhanced CT. These 22 patients were excluded from this study because their conditions were determined inappropriate for the study concept. Finally, the remaining 14 patients (9 males, 5 females; mean age, 67.9 years) with 14 HCCs (mean diameter, 20.3 mm; range 13-31 mm) who had undergone both DCE-MRI using r-VIBE-KWIC and dyn-CTHA before surgery were selected for this study. Three patients were infected with hepatitis B virus, eight with hepatitis C virus, and two with both hepatitis B and C virus; one patient had alcoholic liver disease. Liver function was evaluated with the Child-Pugh classification system; all patients had class A liver function.
DCE-MRI
All MR images were obtained with a 3-T MRI unit (MAG-NETOM Trio; Siemens Healthcare, Erlangen, Germany) using a standard body array coil with six channels and a spine matrix coil with six channels provided by the manufacturer. The scan parameters of DCE-MRI using r-VIBE-KWIC are shown in Table 1 .
The arterial phase of DCE-MRI was performed using r-VIBE-KWIC reconstruction (eight sub-frames; temporal resolution, 2.6-3.0 s) 25 s after the beginning of venous injection of Gd-EOB-DTPA (injection rate, 2 ml/s), followed by the portal venous phase (45 s after arterial phase; fullframe images; temporal resolution, 21-24 s) and late phase (90 s after arterial phase; full-frame images; temporal resolution, 21-24 s) ( Fig. 1 ).
CTHA
CTHA was performed using 16-row multislice CT machines from two manufacturers (Aquilion 16; Toshiba Medical Systems, Otawara, Tochigi, Japan, and Sensation 16; Siemens Healthcare, Erlangen, Germany) after an angiographic catheter had been positioned in the common hepatic artery or replaced the right/left hepatic artery. First, CTHA including the whole liver was performed 5 s after starting injection of the contrast medium (1 ml/s; total dose, 30 ml), followed by a second-phase scan 30 s after the first scan. The dyn-CTHA scan location was based on the CTHA findings. After an interval of more than 5 min, dyn-CTHA scanning began immediately before injection of the contrast medium (1 ml/s; total dose, 10 ml), and a maximal 60-s continuous scan was obtained in a single breath-hold with inhalation of oxygen (2 ml/s) (Fig. 2) . The parameters of each CT scan were as follows: tube voltage, 130 and 120 kV; tube current, 150 and 200 mA; rotation time, 1.0 and 0.5 s; collimation, 3.6 and 3.0 mm, respectively. Dyn-CTHA was performed in 12 patients by one CT unit using the former parameters and in 2 patients by the other CT unit using the latter parameters. Other parameters were as follows: field of view, 272-360 × 272-360 mm; matrix, 512 × 512. Images of four consecutive slices were reconstructed at 1-s intervals, i.e., temporal resolution of the CT images was 1 s. All dyn-CTHA examinations were performed within 3 weeks before or after DCE-MRI.
Image analysis
Only the arterial phases of DCE-MRI and dyn-CTHA were independently reviewed by two radiologists with 22 and 18 years of abdominal imaging experience, respectively, who were blinded to the patients' clinical backgrounds and pathologic findings, except for the diagnosis of HCC. Disagreement was resolved by discussion and consensus. Tumorenhancing findings such as early staining, peritumoral signal/attenuation, corona enhancement, and washout were analyzed on both DCE-MRI and dyn-CTHA.
A detailed description of each finding is presented below.
• Early staining Stronger enhancement of the tumor than of the adjacent liver parenchyma on the arterial phase of DCE-MRI or dyn-CTHA soon after injection of the contrast agent (Figs. 3, 4 ).
• Peritumoral low-intensity or -density band Low-signal or -density band observed around the enhancing tumor (Figs. 3, 4 ).
• Corona enhancement Enhancement projected into the surrounding liver after enhancement of the whole tumor [4] (Fig. 3 ).
• Washout Intratumoral low-intensity area (at late arterial phase of DCE-MRI) or low-density area (in any phase of dyn-CTHA) compared with adjacent liver parenchyma after early staining (Figs. 4, 5 ). The time point at which washout appeared was analyzed on dyn-CTHA, and the tumor enhancement time (defined as the duration for which the tumor was seen as a high-density/-intensity area compared with adjacent liver parenchyma) was assessed on both DCE-MRI and dyn-CTHA. If tumor enhancement was seen on one series of Fig. 3 A 66-year-old male with hepatocellular carcinoma. Early staining, a peritumoral low-intensity/-density band (white arrowheads), and corona enhancement (thin arrows) are seen on the arterial phase of DCE-MRI (upper row) and dyn-CTHA (lower row). DCE-MRI dynamic contrast-enhanced magnetic resonance imaging, dyn-CTHA dynamic computed tomography during hepatic arteriography Fig. 4 A 66-year-old female with hepatocellular carcinoma. Early staining, peritumoral low-intensity/-density band, (small white arrows), and partial washout (white arrows) are seen on the arterial phase of DCE-MRI (upper row) and dyn-CTHA (lower row). DCE-MRI dynamic contrast-enhanced magnetic resonance imaging, dyn-CTHA dynamic computed tomography during hepatic arteriography sub-frame images on DCE-MRI, the tumor enhancement time was considered to be 3 s. If enhancement was seen on two series of sub-frame images, it was considered to be 6 s. On dyn-CTHA, the tumor enhancement time was considered to be the number of image series on which tumor enhancement was seen. The correlation of and difference in the tumor enhancement time between DCE-MRI and dyn-CTHA were analyzed using Spearman's rank correlation coefficient and Wilcoxon's signed rank test, respectively. P < 0.05 was considered to indicate a statistically significant difference. Statistical analyses were performed with a commercial software package (Prism, ver. 7; GraphPad Software, La Jolla, CA, USA) and Microsoft Excel 2016 (Microsoft, Redmond, WA, USA). 
Statistical analysis

Results
A summary of the findings in each patient is shown in Table 2 . Four findings were observed with both diagnostic imaging techniques: early staining, peritumoral lowintensity or -density bands, corona enhancement, and washout of HCC. In all patients, early staining was seen at the arterial phase of DCE-MRI and dyn-CTHA. On DCE-MRI, all cases of early staining, low-intensity or -density bands around the tumor, and corona enhancement were observed at the arterial phase (Fig. 3) . All cases of corona enhancement were seen on the arterial phase of DCE-MRI, especially in the seventh or eighth sub-frame (late arterial phase) (Fig. 3) . Partial washout was seen on the seventh or eighth sub-frame images of the arterial phase of DCE-MRI in four patients and on dyn-CTHA in all patients; the median washout appearance time was 25 s (range 12-45 s) after the beginning of early staining (Fig. 4) . Whole washout was seen at the portal venous phase of DCE-MRI in 11 patients and in the second phase of CTHA in all patients; it was not seen on DCE-MRI in 2 patients (Fig. 5) .
Pathologically, a fibrous capsule was observed in 8 of 14 HCCs. It was seen in 7 of 10 HCCs with peritumoral low intensity on DCE-MRI and in 7 of 12 HCCs with peritumoral low density on dyn-CTHA.
The findings of early staining on DCE-MRI/dyn-CTHA, corona enhancement on dyn-CTHA, and washout on dyn-CTHA were fully matched between the two readers as positive findings. The kappa values of peritumoral lowsignal/-density bands on DCE-MRI/dyn-CTHA, corona enhancement on DCE-MRI, and washout on DCE-MRI were 0.8108/0.6316, 0.7586, and 0.6889, respectively. There were no findings of poor, fair, or moderate interreader agreement.
The median tumor enhancement time on r-VIBE-KWIC and dyn-CTHA was 24 s (range 9-24 s) and 23 s (range 8-35 s), respectively. The correlation coefficient of the tumor enhancement time between the two diagnostic imaging techniques was 0.762 (P = 0.002). There was no statistically significant difference between the two methods (P = 0.2981).
Discussion
On MRI, balancing the competing goals of image quality and high temporal resolution is challenging because a tradeoff between image quality and acquisition time becomes unavoidable. Various MR sequences with high temporal resolution have been reported, and the feasibility of DCE-MRI for liver evaluation has been analyzed [9] [10] [11] [12] . However, these techniques degrade the image quality or temporal fidelity. Some previous studies have been performed using nonspecific extracellular contrast agents, which have an advantage over Gd-EOB-DTPA with respect to arterial enhancement [13] [14] [15] . In addition, some problems have been reported in the arterial phase of DCE-MRI using Gd-EOB-DTPA, such as suboptimal timing and transient severe motion [8, 16, 17] . The r-VIBE-KWIC sequence is one candidate for overcoming these problems because it has motion resistance and provides images with high temporal resolution without degradation of the image quality in the arterial phase of DCE-MRI [8] .
With respect to the assessment of the detailed arterial hemodynamics of HCC, CTHA (especially dyn-CTHA) has been considered the gold standard for the evaluation of early staining, corona enhancement, and washout. To the best of our knowledge, no studies have compared the findings of DCE-MRI and dyn-CTHA. Because dyn-CTHA is a relatively invasive technique with the added drawback of radiation exposure and its scan coverage is more limited than that of DCE-MRI, it is very useful to obtain dyn-CTHA-like images by DCE-MRI for accurate diagnosis.
In the present study, all hypervascular HCCs were accurately demonstrated on DCE-MRI. This suggests that the optimal timing of the arterial phase and adequate arterial enhancement were obtained in DCE-MRI using r-VIBE-KWIC. These phenomena were validated by Fujinaga et al. [8] .
Peritumoral low-intensity or low-density bands, which have not been previously reported, were seen on DCE-MRI in 83% of HCCs. Initially, we suspected that this finding corresponded to the pseudocapsule of HCC. However, of 12 HCCs with a low-density band around the tumor on dyn-CTHA, 4 had no pseudocapsule on pathologic examination. Because a detailed correlation between the radiologic and pathologic findings was not performed in this study, the significance of this finding remains uncertain. Corona enhancement, which is always observed in HCCs on dyn-CTHA [4] , was evaluated on DCE-MRI in 78% of HCCs in this study. It appeared as a transient corona or wedged-shaped enhancement just after tumor enhancement, and the shape of the enhancement on DCE-MRI and dyn-CTHA was the same in each patient. Ueda et al. [4] reported that contrast enhancement of the adjacent liver and corona enhancement began 10.5 ± 2.2 and 22.4 ± 6.1 s after the start of the injection, respectively. High temporal resolution of the images was needed to demonstrate this finding. In the present study, detailed serial arterial hemodynamic changes of HCC were clearly evaluated on DCE-MRI using r-VIBE-KWIC. However, corona enhancement was not observed in three patients. We speculate that there are two reasons for this phenomenon. One might be the failure to obtain optimal arterial phase images because of the shorter scan time of DCE-MRI (24 s) than dynamic CTHA (60 s). Another factor might be the increased signal intensity in the adjacent region because of the portal venous flow on the DCE-MRI.
Partial washout was seen only in 29% of HCCs on the arterial phase of DCE-MRI, although it was seen in all HCCs on dyn-CTHA. We attribute this phenomenon to differences in the acquisition and scan times, i.e., the acquisition time of DCE-MRI was shorter than the scan time of dyn-CTHA. In other words, this result indicates that early staining would be underestimated in the arterial phase of DCE-MRI when the acquisition time is long. This occurs because washout of HCC begins in the arterial phase of DCE-MRI, and the coexistence of early staining (high signal intensity) and washout (low signal intensity) in the arterial phase results an averaged signal between them.
In two HCCs, washout was not seen on DCE-MRI although it was seen on CTHA. In these patients, the HCC was shown as a hyperintense area compared with the adjacent liver (Fig. 5) . This seems to be one of the pitfalls in assessing washout on DCE-MRI.
The concordance rate of each finding on both modalities was acceptable because some findings were fully matched between the two readers and others showed good or excellent interreader agreement.
Our study has some limitations. First, only a small number of patients who underwent hepatic resection were analyzed. Second, the MRI scan parameters varied, and two different CT systems were used. A prospective study might be required to overcome this problem. Third, the maximum tumor enhancement time on DCE-MRI was limited to ≤ 24 s because the acquisition time of DCE-MRI was limited. However, oxygen inhalation may allow for a longer breath-hold time comparable with dyn-CTHA.
In conclusion, DCE-MRI with high temporal resolution using r-VIBE-KWIC has diagnostic potential comparable with that of dyn-CTHA in the hemodynamic evaluation of HCC except for the washout phenomenon.
